Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NATIONAL HEALTHCARE CORPNHC · Entity 355 | Director · CEO | August 19, 2026 | August 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NATIONAL HEALTHCARE CORP
Report date August 19, 2026 · Filed August 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 65,487 |
Reported balance
After 2026-08-19 transaction · row 1
1 source rowRow 1 · 2026-08-19 · Sale · Disposed 1,500 · Balance 65,487 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $53.94 · Expires 2028-03-08 | Direct | 4,294 |
Reported balance
Holding disclosure · report date 2026-08-19 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 4,294 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $94.10 · Expires 2029-03-05 | Direct | 5,000 |
Reported balance
Holding disclosure · report date 2026-08-19 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 5,000 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $90.62 · Expires 2030-02-28 | Direct | 12,000 |
Reported balance
Holding disclosure · report date 2026-08-19 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 12,000 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $157.13 · Expires 2031-02-23 | Direct | 20,000 |
Reported balance
Holding disclosure · report date 2026-08-19 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 20,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2024 Filed Feb 26, 2024 22:53 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock | 4,733 | $63.96 | $302,722.68 |
DisclosureSEC source: 0001437749-24-005586 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,403 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 22:40 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 998 | $92.42 | $92,235.16 |
DisclosureSEC source: 0001437749-24-000453 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,670 F1 · shares: On 1/1/2024, 33 1/3 (or 2,651 shares) of restricted stock originally granted on 2/24/2021, 2/25/2022, and 3/8/2023 vested. The Company withheld 998 shares to pay tax obligations. Read SEC document |
| November 21, 2023 Filed Nov 22, 2023 21:50 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 4,733 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-23-032908 · rdgdoc.xml · derivative · entry 4 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,467 Underlying: Common Stock · 14,200 shares Expires 2027-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 21, 2023 Filed Nov 22, 2023 21:50 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 4,261 | $77.33 | $329,503.13 |
DisclosureSEC source: 0001437749-23-032908 · rdgdoc.xml · nonDerivative · entry 3 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,668 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| November 21, 2023 Filed Nov 22, 2023 21:50 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock | 4,733 | $63.96 | $302,722.68 |
DisclosureSEC source: 0001437749-23-032908 · rdgdoc.xml · nonDerivative · entry 2 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,929 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 21, 2023 Filed Nov 29, 2023 21:38 UTC Amendment | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 4,733 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-23-033181 · rdgdoc.xml · derivative · entry 4 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,467 Underlying: Common Stock · 14,200 shares Expires 2027-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 21, 2023 Filed Nov 29, 2023 21:38 UTC Amendment | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 4,261 | $77.33 | $329,503.13 |
DisclosureSEC source: 0001437749-23-033181 · rdgdoc.xml · nonDerivative · entry 3 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,340 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| November 21, 2023 Filed Nov 29, 2023 21:38 UTC Amendment | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock | 4,733 | $63.96 | $302,722.68 |
DisclosureSEC source: 0001437749-23-033181 · rdgdoc.xml · nonDerivative · entry 2 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 17, 2023 Filed Nov 29, 2023 21:38 UTC Amendment | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GiftCommon Stock | 800 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-033181 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,868 F4 · date: The date of the reported gifting transaction was previously reported as November 16, 2023 and is corrected here to be November 17, 2023. Read SEC document |
| November 16, 2023 Filed Nov 22, 2023 21:50 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GiftCommon Stock | 800 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-032908 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,196 Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 23:15 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 15,000 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-23-006023 · rdgdoc.xml · derivative · entry 3 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2028-03-08 F2 · shares: These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F3 · derivative.exercise_date: This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on March 8, 2024; one-third (1/3) will vest on March 8, 2025; and the final one-third (1/3) will vest on March 8, 2026. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 23:15 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantCommon Stock | 1,502 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-006023 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,996 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2024, the next 33 1/3% vesting on 1/1/2025, and the final 33 1/3% vesting on 1/1/2026. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 22:28 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 824 | $59.50 | $49,028.00 |
DisclosureSEC source: 0001437749-23-000355 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,494 F1 · shares: On 1/1/2023, 33 1/3 (or 2,780 shares) of restricted stock originally granted on 2/21/2020, 2/24/2021, and 2/25/2022 vested. The Company withheld 824 to pay tax obligations. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 22:04 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantCommon Stock | 4,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004912 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,318 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2023, the next 33 1/3% vesting on 1/1/2024, and the final 33 1/3% vesting on 1/1/2025. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 21:37 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 14,200 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-22-004195 · rdgdoc.xml · derivative · entry 3 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,200 Underlying: Common Stock · 14,200 shares Expires 2027-02-18 F1 · shares: These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 18, 2023; one-third (1/3) will vest on February 18, 2024; and the final one-third (1/3) will vest on February 18, 2025. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 22:38 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 577 | $67.94 | $39,201.38 |
DisclosureSEC source: 0001437749-22-000323 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,518 F1 · shares: On 1/1/2022, 33 1/3 (or 1,948 shares) of restricted stock originally granted on 2/22/2019, 2/21/2020, and 2/24/2021 vested. The Company withheld 577 shares to pay tax obligations. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 22:59 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 40,000 | $0.00 Strike: $72.94 | $0.00 |
DisclosureSEC source: 0001437749-21-025974 · rdgdoc.xml · derivative · entry 3 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 45,000 shares Expires 2022-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2017. On February 11, 2021, the Compensation Committee amended the options to grant the ability to exercise up to 100% of these options, with any shares issued upon exercise to be held as restricted stock until February 9, 2022, the original vesting date. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2017. On February 11, 2021, the Compensation Committee amended the options to grant the ability to exercise up to 100% of these options, with any shares issued upon exercise to be held as restricted stock until February 9, 2022, the original vesting date. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 22:59 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock held in my name | 38,633 | $76.35 | $2,949,629.55 |
DisclosureSEC source: 0001437749-21-025974 · rdgdoc.xml · nonDerivative · entry 2 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,095 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 22:59 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock held in my name | 40,000 | $72.94 | $2,917,600.00 |
DisclosureSEC source: 0001437749-21-025974 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2017. On February 11, 2021, the Compensation Committee amended the options to grant the ability to exercise up to 100% of these options, with any shares issued upon exercise to be held as restricted stock until February 9, 2022, the original vesting date. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 17:24 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantCommon Stock | 1,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-004203 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,728 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2022, the next 33 1/3% vesting on 1/1/2023, and the final 33 1/3% vesting on 1/1/2024. Read SEC document |
| January 01, 2021 Filed Jan 8, 2021 20:11 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 414 | $66.41 | $27,493.74 |
DisclosureSEC source: 0001437749-21-000398 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,078 F1 · shares: On 1/1/2021, 33 1/3 (or 1,399 shares) of restricted stock originally granted on 2/22/2019 and 2/21/2020 vested. The Company withheld 414 shares to pay tax obligations. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:03 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantCommon Stock | 1,892 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-003490 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,492 F1 · shares: Restricted shares subject to a three-year vesting schedule. The shares will vest 33 1/3% on 1/1/2021, 66 2/3% on 1/1/2022, and 100% on 1/1/2023. Read SEC document |
| January 02, 2020 Filed Jan 17, 2020 16:41 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 227 | $86.48 | $19,630.96 |
DisclosureSEC source: 0001437749-20-000765 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,600 F1 · shares: On 1/1/2020 33 1/3 (or 768 shares) of restricted shares originally granted on 2/22/2019 vested. The Company withheld 227 shares to pay tax obligations. Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 22:55 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantCommon Stock | 2,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-003297 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,827 F1 · shares: Restricted shares subject to a three-year vesting schedule. The shares will vest 33 1/3% on 1/1/2020, 66 2/3% on 1/1/2021, and 100% on 1/1/2022. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:51 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 30,000 | $0.00 Strike: $72.94 | $0.00 |
DisclosureSEC source: 0001437749-19-003082 · rdgdoc.xml · derivative · entry 3 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 75,000 shares Expires 2022-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive plan on March 14, 2017. On February 14, 2019, the Compensation Committee amended the option to grant a 30 day window to exercise up to 40% of this option, with any shares issued upon exercise to be held as restricted stock until 2/9/22, the original date exercisable. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive plan on March 14, 2017. On February 14, 2019, the Compensation Committee amended the option to grant a 30 day window to exercise up to 40% of this option, with any shares issued upon exercise to be held as restricted stock until 2/9/22, the original date exercisable. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:51 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 27,160 | $84.03 | $2,282,254.80 |
DisclosureSEC source: 0001437749-19-003082 · rdgdoc.xml · nonDerivative · entry 2 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,524 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of common shares owned following transactions reported on this form. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:51 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock | 30,000 | $72.94 | $2,188,200.00 |
DisclosureSEC source: 0001437749-19-003082 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,684 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive plan on March 14, 2017. On February 14, 2019, the Compensation Committee amended the option to grant a 30 day window to exercise up to 40% of this option, with any shares issued upon exercise to be held as restricted stock until 2/9/22, the original date exercisable. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| September 21, 2017 Filed Feb 13, 2018 16:16 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GiftCommon Stock | 2,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-002309 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,684 Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 19:43 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 75,000 | $0.00 Strike: $72.94 | $0.00 |
DisclosureSEC source: 0001047335-17-000069 · edgar.xml · derivative · entry 2 Flatt Stephen Fowler · CIK 0001330766 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2022-03-11 F1 · shares: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive plan on March 14, 2017. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| December 21, 2016 Filed Feb 10, 2017 20:39 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GiftCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001047335-17-000024 · edgar.xml · nonDerivative · entry 2 Flatt Stephen Fowler · CIK 0001330766 · CEO (formerly President) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,984 Read SEC document |
| December 09, 2016 Filed Feb 10, 2017 20:39 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GiftCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001047335-17-000024 · edgar.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · CEO (formerly President) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · balance_after: Transaction totaled below Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.